NeuroSense Therapeutics NRSN
NASDAQ NRSN
$6.62 +0.27 (+4.25%)
At close: Sep 21, 2026 · 4:00 PM EDT

NeuroSense Therapeutics (NRSN) Property, Plant & Equipment (Net) Growth (3y) (2023 - 2025)

Analysis

NeuroSense Therapeutics (NRSN) Property, Plant & Equipment (Net) Growth (3y) (2023 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (3y) (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn 15.61%
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn 1.73%
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn 14.05%
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn 11.65%
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn -3.34%
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn 411.50%
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn 1.66%
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn -3.26%
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn -
10 NeuroSense Therapeutics 8.09 Mn 7.88 Mn - -9.38%
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -9.38%
Jun 30, 2025 -28.42%
Dec 31, 2024 108.82%
Dec 31, 2023 174.54%
API Access

NeuroSense Therapeutics Property, Plant & Equipment (Net) Growth (3y) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=property-plant-and-equipment-net-growth-3y&ticker=NRSN&period=max&api_key=YOUR_API_KEY